April 2017

VENTURE CAPITAL – Duteil Avocats (Benoît Lespinasse) advised IXO PRIVATE EQUITY in relation with a 4,6M€ round in the company LABORATOIRES CYCLOPHARMA.

This fundraising will enable LABORATOIRES CYCLOPHARMA to develop new molecules for personalized medicine and grow on international markets.

Since 2014, LABORATOIRES CYCLOPHARMA’s R&D budget has doubled and now represents more than 20% of revenues, to research, develop and market one innovative molecule per year until 2020. LABORATOIRES CYCLOPHARMA aims to double its revenues by 2020.

April 2017